author-photo

Dih-Yih Chen

9

Papers

92

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Phase 2 Study of Zanubrutinib in BTK Inhibitor-Intolerant Patients (Pts) with Relapsed/Refractory B-Cell Malignancies

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Trial in progress: a phase II, multicenter, single-arm study of zanubrutinib (BGB-3111) in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma intolerant of prior treatment with ibrutinib.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 2 Study of Zanubrutinib in Patients with Relapsed/Refractory B-Cell Malignancies Intolerant to Ibrutinib/Acalabrutinib

2020 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Acalabrutinib in Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): Updated Results from the Phase 1/2 ACE-CL-001 Study

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Acalabrutinib in Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): Updated Results from the Phase 1/2 ACE-CL-001 Study

2018 Blood
Show All
- Source
- Cite
- Save
Citations (18)
Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERT.

2007 Cancer Biology & Therapy
Show All
- Source
- Cite
- Save
Citations (19)